Avinger to Announce First Quarter 2021 Results on May 6, 2021

Rhea-AI Summary

Avinger, Inc. (NASDAQ:AVGR) is set to release its financial results for Q1 2021 on May 6, 2021, after market close. The company, a leader in intravascular imaging technology for diagnosing and treating Peripheral Artery Disease (PAD), will host a conference call at 1:30 PM PT/4:30 PM ET. The call can be accessed by dialing +1-862-298-0850 or via a live webcast on its investor relations page. Avinger focuses on revolutionizing vascular disease treatment with its Lumivascular platform, impacting over 12 million PAD patients in the U.S.

REDWOOD CITY, CA / ACCESSWIRE / April 26, 2021 / Avinger, Inc. (NASDAQ:AVGR), commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of Peripheral Artery Disease (PAD), today announced that it will release its financial results for the first quarter 2021 after the close of trading on Thursday, May 6, 2021. The Company will host a conference call beginning at 1:30pm PT/4:30pm ET.

To join the call by telephone, please dial +1-862-298-0850. A live webcast of the conference call will be available online from the investor relations page of the Company's corporate website at http://www.avinger.com.

A replay of the webcast will be made available on Avinger's website, www.avinger.com, shortly after completion of the call.

About Avinger, Inc.

Avinger is a commercial-stage medical device company that designs and develops the first and only image-guided, catheter-based system for the diagnosis and treatment of patients with Peripheral Artery Disease (PAD). PAD is estimated to affect over 12 million people in the U.S. and over 200 million worldwide. Avinger is dedicated to radically changing the way vascular disease is treated through its Lumivascular platform, which currently consists of the Lightbox imaging console, the Ocelot and Tigereye^TM family of chronic total occlusion (CTO) catheters, and the Pantheris® family of atherectomy devices. Avinger is based in Redwood City, California. For more information, please visit www.avinger.com.

Follow Avinger on Twitter and Facebook.

Investor Contact:

Mark Weinswig
Chief Financial Officer
Avinger, Inc.
(650) 241-7916
ir@avinger.com

Matt Kreps
Darrow Associates Investor Relations
(214) 597-8200
mkreps@darrowir.com

SOURCE: Avinger, Inc.

View source version on accesswire.com:
https://www.accesswire.com/641958/Avinger-to-Announce-First-Quarter-2021-Results-on-May-6-2021

FAQ

When will Avinger release its Q1 2021 financial results?

Avinger will release its Q1 2021 financial results on May 6, 2021.

What time will Avinger hold its conference call?

Avinger will hold its conference call at 1:30 PM PT (4:30 PM ET) on May 6, 2021.

How can I access Avinger's conference call?

You can access Avinger's conference call by dialing +1-862-298-0850 or through a live webcast on their investor relations page.

What is Avinger's focus in the medical industry?

Avinger focuses on developing image-guided, catheter-based systems for the diagnosis and treatment of Peripheral Artery Disease (PAD).

How many people are estimated to be affected by PAD in the U.S.?

Over 12 million people in the U.S. are estimated to be affected by Peripheral Artery Disease (PAD).